Employees Retirement System of Texas’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-31
Closed -$81K 1096
2018
Q2
$81K Hold
31
﹤0.01% 1065
2018
Q1
$73K Hold
31
﹤0.01% 1035
2017
Q4
$124K Hold
31
﹤0.01% 1025
2017
Q3
$127K Hold
31
﹤0.01% 1004
2017
Q2
$140K Hold
31
﹤0.01% 999
2017
Q1
$167K Hold
31
﹤0.01% 1010
2016
Q4
$137K Hold
31
﹤0.01% 1004
2016
Q3
$644K Buy
31
+12
+63% +$217K 0.01% 874
2016
Q2
$287K Hold
19
﹤0.01% 915
2016
Q1
$520K Hold
19
0.01% 878
2015
Q4
$539K Buy
19
+8
+73% +$264K 0.01% 863
2015
Q3
$280K Buy
11
+2
+22% +$135K ﹤0.01% 907
2015
Q2
$752K Buy
+9
New +$824K 0.01% 823

Other funds holding TPST

Employees Retirement System of Texas's TPST Position: Q3 2018 in Review

Employees Retirement System of Texas sold out of Tempest Therapeutics (TPST) in Q3 2018, closing a stake of 31 shares — an estimated $81K sold.

Employees Retirement System of Texas first reported a position in TPST in Q2 2015 and held it in 13 quarters. The position peaked at $752K in Q2 2015. 35 funds tracked by Wall St. Rank hold TPST as of Q3 2018.

  • Employees Retirement System of Texas reported no remaining Tempest Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Employees Retirement System of Texas sold 31 Tempest Therapeutics shares in Q3 2018, an estimated $81K.
  • Employees Retirement System of Texas first reported a position in Tempest Therapeutics in Q2 2015 and held it in 13 quarters.
  • Employees Retirement System of Texas's Tempest Therapeutics position peaked at $752K in Q2 2015.
  • 35 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2018.

Based on Employees Retirement System of Texas's 13F filing for Q3 2018, filed 13 Nov 2018.